Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the…

By D. Diekema, M. Pfaller, F. Schmitz, J. Smayevsky, J. Bell, R. N. Jones, M. Beach. Clinical Infectious Diseases, 2001

1,504 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/63b56a37017134ff2d48c7c2556aa89fdb9856da

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. E. Stobberingh
2. R. H. Deurenberg
3. 古谷 良輔
4. 山口 和将
5. F. Lowy

In Infectious Diseases

1. E. Stobberingh
2. R. H. Deurenberg
3. A. Kramer
4. F. Lowy
5. G. Kampf
6. K. Poole

In Public Health, Environmental and Occupational Health

1. F. Lowy

Citations in the corpus

• Prosthetic Joint Infection (2014, background): “This is in contrast to other Staphylococcus species, where -lactamase production is common (137).”
• Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and Rubs (2004, background): “aureus (MRSA) is increasing worldwide (113, 503, 578), leading not only to NIs but recently also to community-acquired infection.”
• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications (2010, background): “detected very low rates of hVISA (70, 133, 165, 341); however,”
• Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria (2006, background): “Many MRSA strains then evolved to become resistant to fluoroquinolones and became widely disseminated, such that for some countries the predominant clones of MRSA are often fluoroquinolone resistant (39).”
• Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? (2006, neutral): “posing risk factors, including surgery [1].”
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (2004, background): “In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
• Antimicrobial resistance: the example of Staphylococcus aureus. (2003, background): “aureus is now the leading overall cause of nosocomial infections and, as more patients are treated outside the hospital setting, is an increasing concern in the community (7, 8).”
• The evolution of Staphylococcus aureus. (2008, background): “A study recently performed among veterinarians who attended an international pig-health meeting in Denmark observed that 12.5% of the participants, coming from Canada and various countries in Europe, carried the pig-related MRSA clone (Wulf et al., 2008).”
• The molecular evolution of methicillin-resistant Staphylococcus aureus. (2007, neutral): “3% in Europe [113,114].”